US Stock MarketDetailed Quotes

APLT Applied Therapeutics

Watchlist

4.670
+0.070+1.52%

Close Jun 28 16:00 ET

4.659
-0.012-0.25%

Post 19:40 ET

533.63MMarket Cap-2445P/E (TTM)

Applied Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-98.22%190K

9.99M

-667K

10.66M

Operating revenue

-98.22%190K

--9.99M

---667K

--0

--10.66M

--0

Cost of revenue

Gross profit

Operating expense

-1.09%21.28M

-10.15%74.53M

7.22%20.34M

-19.95%15.5M

-20.19%17.18M

-6.85%21.52M

-21.46%82.95M

-30.03%18.97M

-31.92%19.36M

-16.83%21.52M

Selling and administrative expenses

62.39%9.07M

-24.50%20.62M

-26.77%5.04M

-24.52%4.71M

-13.58%5.29M

-30.83%5.58M

-36.55%27.32M

-39.60%6.88M

-42.40%6.24M

-44.69%6.13M

-General and administrative expense

62.39%9.07M

-24.50%20.62M

-26.77%5.04M

-24.52%4.71M

-13.58%5.29M

-30.83%5.58M

-36.55%27.32M

-39.60%6.88M

-42.40%6.24M

-44.69%6.13M

Research and development costs

-23.33%12.22M

-3.11%53.91M

26.55%15.3M

-17.77%10.79M

-22.82%11.88M

6.02%15.94M

-11.09%55.63M

-23.10%12.09M

-25.46%13.12M

4.01%15.4M

Operating profit

-94.26%-21.09M

22.20%-64.54M

-10.73%-21.01M

19.95%-15.5M

20.19%-17.18M

53.00%-10.86M

21.46%-82.95M

30.03%-18.97M

31.92%-19.36M

16.83%-21.52M

Net non-operating interest income expense

165.16%586K

100.29%1.37M

29.89%352K

72.69%392K

267.57%408K

190.79%221K

23.42%685K

15.81%271K

198.68%227K

-34.32%111K

Non-operating interest income

165.16%586K

100.29%1.37M

29.89%352K

72.69%392K

267.57%408K

190.79%221K

--685K

--271K

198.68%227K

-34.32%111K

Other net income (expense)

-12,786.20%-63.43M

-23,192.18%-56.6M

-498.48%-17.02M

-97,482.14%-27.27M

-188.04%-12.81M

620.83%500K

53.36%-243K

1,631.18%4.27M

143.75%28K

-3,545.08%-4.45M

Gain on sale of security

-13,619.19%-63.41M

-85,616.67%-56.57M

-498.64%-16.96M

-75,869.44%-27.28M

-193.87%-12.8M

--469K

---66K

--4.26M

--36K

---4.36M

Other non- operating income (expenses)

-183.87%-26K

84.75%-27K

-458.82%-61K

225.00%10K

94.44%-5K

132.29%31K

66.03%-177K

106.09%17K

87.50%-8K

26.23%-90K

Income before tax

-728.04%-83.94M

-45.15%-119.76M

-161.13%-37.68M

-121.82%-42.37M

-14.39%-29.58M

56.16%-10.14M

21.86%-82.51M

46.87%-14.43M

32.79%-19.1M

-0.11%-25.86M

Income tax

Net income

-728.04%-83.94M

-45.15%-119.76M

-161.13%-37.68M

-121.82%-42.37M

-14.39%-29.58M

56.16%-10.14M

21.86%-82.51M

46.87%-14.43M

32.79%-19.1M

-0.11%-25.86M

Net income continuous Operations

-728.04%-83.94M

-45.15%-119.76M

-161.13%-37.68M

-121.82%-42.37M

-14.39%-29.58M

56.16%-10.14M

21.86%-82.51M

46.87%-14.43M

32.79%-19.1M

-0.11%-25.86M

Minority interest income

Net income attributable to the parent company

-728.04%-83.94M

-45.15%-119.76M

-161.13%-37.68M

-121.82%-42.37M

-14.39%-29.58M

56.16%-10.14M

21.86%-82.51M

46.87%-14.43M

32.79%-19.1M

-0.11%-25.86M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-728.04%-83.94M

-45.15%-119.76M

-161.13%-37.68M

-121.82%-42.37M

-14.39%-29.58M

56.16%-10.14M

21.86%-82.51M

46.87%-14.43M

32.79%-19.1M

-0.11%-25.86M

Basic earnings per share

-272.22%-0.67

34.86%-1.42

-106.25%-0.33

-17.50%-0.47

61.46%-0.37

79.55%-0.18

47.09%-2.18

84.62%-0.16

63.30%-0.4

3.03%-0.96

Diluted earnings per share

-272.22%-0.67

34.86%-1.42

-106.25%-0.33

-17.50%-0.47

61.46%-0.37

79.55%-0.18

47.09%-2.18

84.62%-0.16

63.30%-0.4

3.03%-0.96

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	-98.22%190K	9.99M	-667K	0	0	10.66M	0	0	0	0
Operating revenue	-98.22%190K	--9.99M	---667K	--0	--0	--10.66M	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-1.09%21.28M	-10.15%74.53M	7.22%20.34M	-19.95%15.5M	-20.19%17.18M	-6.85%21.52M	-21.46%82.95M	-30.03%18.97M	-31.92%19.36M	-16.83%21.52M
Selling and administrative expenses	62.39%9.07M	-24.50%20.62M	-26.77%5.04M	-24.52%4.71M	-13.58%5.29M	-30.83%5.58M	-36.55%27.32M	-39.60%6.88M	-42.40%6.24M	-44.69%6.13M
-General and administrative expense	62.39%9.07M	-24.50%20.62M	-26.77%5.04M	-24.52%4.71M	-13.58%5.29M	-30.83%5.58M	-36.55%27.32M	-39.60%6.88M	-42.40%6.24M	-44.69%6.13M
Research and development costs	-23.33%12.22M	-3.11%53.91M	26.55%15.3M	-17.77%10.79M	-22.82%11.88M	6.02%15.94M	-11.09%55.63M	-23.10%12.09M	-25.46%13.12M	4.01%15.4M
Operating profit	-94.26%-21.09M	22.20%-64.54M	-10.73%-21.01M	19.95%-15.5M	20.19%-17.18M	53.00%-10.86M	21.46%-82.95M	30.03%-18.97M	31.92%-19.36M	16.83%-21.52M
Net non-operating interest income expense	165.16%586K	100.29%1.37M	29.89%352K	72.69%392K	267.57%408K	190.79%221K	23.42%685K	15.81%271K	198.68%227K	-34.32%111K
Non-operating interest income	165.16%586K	100.29%1.37M	29.89%352K	72.69%392K	267.57%408K	190.79%221K	--685K	--271K	198.68%227K	-34.32%111K
Other net income (expense)	-12,786.20%-63.43M	-23,192.18%-56.6M	-498.48%-17.02M	-97,482.14%-27.27M	-188.04%-12.81M	620.83%500K	53.36%-243K	1,631.18%4.27M	143.75%28K	-3,545.08%-4.45M
Gain on sale of security	-13,619.19%-63.41M	-85,616.67%-56.57M	-498.64%-16.96M	-75,869.44%-27.28M	-193.87%-12.8M	--469K	---66K	--4.26M	--36K	---4.36M
Other non- operating income (expenses)	-183.87%-26K	84.75%-27K	-458.82%-61K	225.00%10K	94.44%-5K	132.29%31K	66.03%-177K	106.09%17K	87.50%-8K	26.23%-90K
Income before tax	-728.04%-83.94M	-45.15%-119.76M	-161.13%-37.68M	-121.82%-42.37M	-14.39%-29.58M	56.16%-10.14M	21.86%-82.51M	46.87%-14.43M	32.79%-19.1M	-0.11%-25.86M
Income tax
Net income	-728.04%-83.94M	-45.15%-119.76M	-161.13%-37.68M	-121.82%-42.37M	-14.39%-29.58M	56.16%-10.14M	21.86%-82.51M	46.87%-14.43M	32.79%-19.1M	-0.11%-25.86M
Net income continuous Operations	-728.04%-83.94M	-45.15%-119.76M	-161.13%-37.68M	-121.82%-42.37M	-14.39%-29.58M	56.16%-10.14M	21.86%-82.51M	46.87%-14.43M	32.79%-19.1M	-0.11%-25.86M
Minority interest income
Net income attributable to the parent company	-728.04%-83.94M	-45.15%-119.76M	-161.13%-37.68M	-121.82%-42.37M	-14.39%-29.58M	56.16%-10.14M	21.86%-82.51M	46.87%-14.43M	32.79%-19.1M	-0.11%-25.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-728.04%-83.94M	-45.15%-119.76M	-161.13%-37.68M	-121.82%-42.37M	-14.39%-29.58M	56.16%-10.14M	21.86%-82.51M	46.87%-14.43M	32.79%-19.1M	-0.11%-25.86M
Basic earnings per share	-272.22%-0.67	34.86%-1.42	-106.25%-0.33	-17.50%-0.47	61.46%-0.37	79.55%-0.18	47.09%-2.18	84.62%-0.16	63.30%-0.4	3.03%-0.96
Diluted earnings per share	-272.22%-0.67	34.86%-1.42	-106.25%-0.33	-17.50%-0.47	61.46%-0.37	79.55%-0.18	47.09%-2.18	84.62%-0.16	63.30%-0.4	3.03%-0.96
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall